Danaher Co. (NYSE:DHR) Declares $0.27 Quarterly Dividend

Danaher Co. (NYSE:DHR) declared a quarterly dividend on Tuesday, May 7th, RTT News reports. Shareholders of record on Friday, June 28th will be given a dividend of 0.27 per share by the conglomerate on Friday, July 26th. This represents a $1.08 annualized dividend and a dividend yield of 0.43%.

Danaher has increased its dividend by an average of 13.4% per year over the last three years and has raised its dividend every year for the last 1 years. Danaher has a payout ratio of 12.5% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Danaher to earn $8.71 per share next year, which means the company should continue to be able to cover its $1.08 annual dividend with an expected future payout ratio of 12.4%.

Danaher Stock Up 0.0 %

NYSE:DHR traded up $0.02 during midday trading on Wednesday, reaching $248.78. The company had a trading volume of 208,531 shares, compared to its average volume of 2,715,680. Danaher has a 12-month low of $182.09 and a 12-month high of $259.00. The stock’s fifty day simple moving average is $248.27 and its 200-day simple moving average is $233.19. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $184.27 billion, a price-to-earnings ratio of 42.18, a PEG ratio of 3.82 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The company had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. During the same period last year, the firm earned $2.36 earnings per share. Danaher’s quarterly revenue was down 2.6% on a year-over-year basis. On average, sell-side analysts anticipate that Danaher will post 7.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Robert W. Baird increased their price target on shares of Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, April 24th. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st. KeyCorp lifted their target price on Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. TD Cowen upped their target price on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Finally, Raymond James lifted their price target on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $267.31.

Insider Buying and Selling at Danaher

In other news, CEO Rainer Blair sold 47,175 shares of Danaher stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total value of $11,756,953.50. Following the sale, the chief executive officer now owns 115,995 shares of the company’s stock, valued at $28,908,273.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the transaction, the senior vice president now directly owns 4,244 shares of the company’s stock, valued at approximately $1,029,891.48. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Rainer Blair sold 47,175 shares of the business’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total value of $11,756,953.50. Following the sale, the chief executive officer now owns 115,995 shares in the company, valued at $28,908,273.90. The disclosure for this sale can be found here. In the last three months, insiders have sold 103,984 shares of company stock valued at $25,997,094. 10.90% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.